Le Lézard
Classified in: Health
Subjects: NPT, PDT

NSF International Launches DNA Authenticatedtm Mark for Dietary Supplement Ingredients


ANN ARBOR, Mich., Feb. 20, 2018 /PRNewswire-USNewswire/ -- For the first time, dietary supplement ingredient suppliers can use an on-label, NSF DNA Authenticatedtm mark to verify the identity and purity of raw ingredients. NSF International recently launched its new, independent testing protocol and verification program for raw botanical ingredients used in the dietary supplement industry.

NSF International Launches DNA Authenticatedtm Mark for Dietary Supplement Ingredients

In addition to DNA authentication of the target species, the testing program also screens for contamination, including common adulterants, toxic adulterants, allergens and fillers. DNA Authenticatedtm verification requires next-generation sequencing (NGS) DNA testing of every lot or batch that bears the mark. Suppliers can provide DNA Authenticatedtm certificates and use the verification mark on shipments of verified ingredients.

"With complex global supply chains and fraudulent ingredients popping up in unexpected places, DNA authentication of raw ingredients is a prudent step for supplement manufacturers who are concerned about the quality and purity of products," said Jesse Miller, Ph.D., Director of Applied Research at NSF International. "With the new DNA Authenticatedtm mark, manufacturers, suppliers and, ultimately, consumers can be absolutely sure the ingredients they choose have been accurately identified."

NSF International maintains a database of validated DNA reference sequences for all relevant botanical ingredient and adulterant species of plants, fungi and probiotic bacteria. Many of NSF International's DNA reference sequences have been obtained as herbarium specimens through partnerships with top institutions such as Harvard University and the University of California, Berkeley.

In addition to DNA authentication, NSF International also tests and certifies dietary supplement products and ingredients to the only American National Standard for dietary supplements (NSF/ANSI 173). More than 1,000 products and ingredients are certified to NSF/ANSI 173. Products that earn NSF's Certified for Sport® certification are independently tested on a lot-by-lot basis for more than 270 athletic banned substances.

NSF International is an independent, global organization that writes standards, and tests and certifies products for the food, water, dietary supplements and consumer goods industries to minimize adverse health effects and protect the environment. Founded in 1944, NSF is committed to protecting human health and safety worldwide. With operations in more than 170 countries, NSF International is a Pan American Health Organization/World Health Organization (WHO) Collaborating Center on Food Safety, Water Quality and Indoor Environment.

CONTACT: Thomas Frey, APR 
[email protected]
+1 734 214 6242

NSF Logo. (PRNewsFoto/NSF International)

SOURCE NSF International


These press releases may also interest you

at 07:45
Sensi.AI, a leader in AI-native, data, and analytics in senior care, today announced the appointment of in-home care leader Bob Roth to its Advisory Board. This partnership is an exciting validation of Sensi.AI's promise to enhance proactive,...

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...



News published on and distributed by: